Cintas Corporation vs Heron Therapeutics Inc — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Cintas Corporation is far larger — about 1336.4× Heron Therapeutics Inc's market cap, and Cintas Corporation pays a 1.01% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| CTAS | HRTX | |
|---|---|---|
Market Cap | $82.15B | $61.47M |
Sector | Industrials | Health |
52-Week High | $225.10 | $1.49 |
52-Week Low | $163.55 | $0.32 |
Enterprise Value | $84.56B | $168.21M |
Dividend Yield | 1.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →